Skip to content

The Efficacy of Light Therapy in improving pain After Anterior Cruciate Ligament Reconstruction ; A Randomized Controlled Clinical Trial

The Efficacy of Light Therapy in improving pain After Anterior Cruciate Ligament Reconstruction ; A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109166
Enrollment
Unknown
Registered
2025-09-14
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior cruciate ligament injury

Interventions

Control Group:Daily 1-hour morning sham treatment using Huizhi goggles (inactive goggles) + Standard Rehabilitation for 2 weeks after enrollment.
Intervention Group:Daily 1-hour morning light therapy using Huizhi goggles + Standard Rehabilitation for 2 weeks after enrollment.

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1)Aged 18 to 40 years. (2)Body Mass Index (BMI): 20-25 kg/m^2. (3)Scheduled for ACLR. (4)knee pain (previous week) score >= 3 on the VAS. (5)Generally healthy, without underlying conditions such as gout, metabolic disorders ,malignancy and so on. (6)No history of chronic smoking or alcohol consumption . (7)No visual impairment, cognitive impairment, severe spinal pathology, neurological injury, severe cardiovascular/cerebrovascular disease, cancer, or severe infectious disease. (8)Voluntary participation and signed informed consent.

Exclusion criteria

Exclusion criteria: (1)Acute illness within past 3 months or uncontrolled chronic disease (except drug-controlled diabetes or hypertension). (2)Comorbid chronic pain conditions such as chronic headache, fibromyalgia ,Complex Regional Pain Syndrome ,rheumatoid arthritis and so on. (3)Current or past psychiatric disorders or bipolar disorder. (4)Alcohol or substance abuse. (5)Ocular issues including retinal disease, eye surgery history, light therapy within past year, photosensitizing medications, or melatonin use. (6)Color blindness and visual impairment with prior light therapy experience. (7)Photosensitive epilepsy. (8)Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Pain Scale(VAS);

Secondary

MeasureTime frame
Central Sensitization Inventory (CSI-25);Pressure Pain Threshold (PPT);Generalized Anxiety Disorder-7 (GAD-7);Assessment of Quality of Life-4D (AQoL-4D);International Knee Documentation Committee (IKDC);Patient Health Questionnaire-9 (PHQ-9);Analgesic Use;

Countries

China

Contacts

Public ContactYangyang Lin

The Sixth Affiliated Hospital of Sun Yat-sen University

linyy49@mail.sysu.edu.cn+86 133 3280 5479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026